SCHEMBL24624451

SCHEMBL24624451

N#Cc1c(-c2ccc(-n3c4ccccc4c4ccccc43)cc2)c(C#N)c(-n2c3ccccc3c3ccccc32)c(-c2ccc(-n3c4ccccc4c4ccccc43)cc2)c1-n1c2ccccc2c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
PDE9A O76083 1/20 0.40
PDE1C Q14123 1/20 0.40
ALDH1A1 P00352 6/20 0.39
HPGD P15428 5/20 0.39
RXFP1 Q9HBX9 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
GAA P10253 2/20 0.39
HTR3A P46098 1/20 0.36
HDAC4 P56524 1/20 0.36
EGFR P00533 1/20 0.36
SRC P12931 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35
LMNA P02545 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24329158 0.95 KDM4E (0.47) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL21378068 0.94 KDM4E (0.46) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL21304042 0.91 KDM4E (0.46) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL18327031 0.91 KDM4E (0.52) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL24623466 0.89 PDE9A (0.43) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL24623461 0.89 KDM4E (0.47) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL21437111 0.89 HTR3A (0.44) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL19268495 0.89 KDM4E (0.50) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL22785984 0.88 KDM4E (0.45) KDM4EATML3MBTL1PDE9APDE1C
SCHEMBL24623470 0.88 AR (0.42) KDM4EATMPDE9APDE1CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223798-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223798-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE CHRM2, CCND3, CCNE2 KDM4E 3685/4885ATM 498/4885L3MBTL1 870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.